These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9107450)

  • 21. Implementation of foetal fibronectin testing: Admissions, maternal interventions and costs at 1 year.
    Parisaei M; Currie J; O'Gorman N; Morris S; David AL
    J Obstet Gynaecol; 2016 Oct; 36(7):888-892. PubMed ID: 27147420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Premature labor and fetal fibronectin in cervical and vaginal secretions].
    Lorenz-Eberhardt G; Weiss PA; Haas J; Pürstner P; Adelwöhrer NE
    Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):414-6. PubMed ID: 7926575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervicovaginal fetal fibronectin concentrations: predictive value of impending birth in postterm pregnancies.
    Mouw RJ; Egberts J; Kragt H; van Roosmalen J
    Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):67-70. PubMed ID: 9758262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial.
    Peaceman AM; Andrews WW; Thorp JM; Cliver SP; Lukes A; Iams JD; Coultrip L; Eriksen N; Holbrook RH; Elliott J; Ingardia C; Pietrantoni M
    Am J Obstet Gynecol; 1997 Jul; 177(1):13-8. PubMed ID: 9240576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of fetal fibronectin in women at risk for preterm delivery.
    Andersen HF
    Clin Obstet Gynecol; 2000 Dec; 43(4):746-58. PubMed ID: 11100292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-Policy Implementation Review of Rapid Fetal Fibronectin (fFN) Testing for Preterm Labour in Alberta.
    Chuck AW; Thanh NX; Chari RS; Wilson RD; Janes-Kelley S; Wesenberg JC
    J Obstet Gynaecol Can; 2016 Jul; 38(7):659-666.e6. PubMed ID: 27591351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preterm labour.
    Terzidou V; Bennett PR
    Curr Opin Obstet Gynecol; 2002 Apr; 14(2):105-13. PubMed ID: 11914686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM; Sener T; Yildiz Z
    Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tocolytics for preterm premature rupture of membranes.
    Mackeen AD; Seibel-Seamon J; Grimes-Dennis J; Baxter JK; Berghella V
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007062. PubMed ID: 21975760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice.
    Lopez RL; Francis JA; Garite TJ; Dubyak JM
    Am J Obstet Gynecol; 2000 May; 182(5):1103-6. PubMed ID: 10819840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preterm labor and preterm premature rupture of the membranes. Diagnosis and management.
    Mercer BM; Lewis R
    Infect Dis Clin North Am; 1997 Mar; 11(1):177-201. PubMed ID: 9067791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot study into the efficacy of foetal fibronectin testing in minimising hospital admissions in women presenting with symptoms of preterm labour: a randomised controlled trial of obstetric and neonatal outcomes.
    Dutta D; Norman JE
    Arch Gynecol Obstet; 2011 Sep; 284(3):559-65. PubMed ID: 20957379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [COMBINED APPLICATION OF FETAL FIBRONECTIN AND INSULIN-LIKE GROWTH FACTOR IN PRETERM DELIVERY DIAGNOSIS--OUR RESULTS].
    Kolev N; Ivanov S; Kozovski I; Kovachev E; Kornovski Y; Bechev B; Ivanova V; Nikolova N
    Akush Ginekol (Sofiia); 2015; 54(3):8-12. PubMed ID: 26137773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the impact of introducing fetal fibronectin assay in the management of preterm labour at Middlemore Hospital, New Zealand.
    Musaad SM; Melson CL; Boswell DR
    Pathology; 2005 Jun; 37(3):226-30. PubMed ID: 16175896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth.
    Malak TM; Sizmur F; Bell SC; Taylor DJ
    Br J Obstet Gynaecol; 1996 Jul; 103(7):648-53. PubMed ID: 8688390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J; Chedraui P; Hidalgo L; Medina M
    J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved management in threatened preterm labour with rapid fetal fibronectin testing.
    Parry E; Singh TG; Dow D; Noovao F
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):240-1. PubMed ID: 16704480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.